Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/6210
DC Field | Value | Language |
---|---|---|
dc.contributor.author | El-Haddad, Nataly W | en_US |
dc.contributor.author | El Kawak, Michelle | en_US |
dc.contributor.author | El Asmar, Khalil | en_US |
dc.contributor.author | Jabbour, Michel E | en_US |
dc.contributor.author | Moussa, Mohamad A | en_US |
dc.contributor.author | Habib, Rima R | en_US |
dc.contributor.author | Dhaini, Hassan R | en_US |
dc.date.accessioned | 2022-11-07T09:27:40Z | - |
dc.date.available | 2022-11-07T09:27:40Z | - |
dc.date.issued | 2022-10-12 | - |
dc.identifier.uri | https://scholarhub.balamand.edu.lb/handle/uob/6210 | - |
dc.description.abstract | Bladder Cancer (BCa) is the tenth most incident malignancy worldwide. BCa is mostly attributed to environmental exposure and lifestyle, particularly tobacco smoking. The Aryl Hydrocarbon Receptor Repressor (AhRR) participates in the induction of many enzymes involved in metabolizing carcinogens, including tobacco smoke components. Additionally, studies have shown that smoking demethylates the (AhRR) gene in blood, suggesting AhRR demethylation as a specific serum smoking biomarker. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | National Library of Medicine | en_US |
dc.subject | FGFR3 | en_US |
dc.subject | Urothelial bladder cancer | en_US |
dc.subject | Methylation | en_US |
dc.subject | Muscle-invasiveness | en_US |
dc.subject | p53 | en_US |
dc.subject | Tobacco smoking | en_US |
dc.title | AhRR methylation contributes to disease progression in urothelial bladder cancer | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.3233/CBM-220002 | - |
dc.identifier.pmid | 36093686 | - |
dc.identifier.scopus | 2-s2.0-85140417977 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85140417977 | - |
dc.contributor.affiliation | Faculty of Medicine | en_US |
dc.description.volume | 35 | en_US |
dc.description.issue | 2 | en_US |
dc.description.startpage | 167 | en_US |
dc.description.endpage | 177 | en_US |
dc.date.catalogued | 2022-11-07 | - |
dc.description.status | Published | en_US |
dc.identifier.openURL | https://content.iospress.com/articles/cancer-biomarkers/cbm220002 | en_US |
dc.relation.ispartoftext | Cancer biomarkers : section A of Disease markers | en_US |
dc.description.campus | SGH campus | en_US |
Appears in Collections: | Faculty of Medicine |
SCOPUSTM
Citations
2
checked on Nov 23, 2024
Record view(s)
62
checked on Nov 22, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.